|

Semaglutide placebo Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Universitaire Ziekenhuizen KU Leuven1
  • Novo Nordisk A/S1

Indications

  • Diabetes2
  • Glucose Intolerance After a Recent History of Gestational Diabetes1
  • Diabetes Mellitus, Type 21

Other1 trial

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Phase 3

Birmingham, Alabama1 trial

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Flourish Research

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.